Walgreens Boots Alliance FY23 Q3 Sales UP 8.6% to $35.4 Billion
- Chaileedo Press
- Jun 28, 2023
- 2 min read
Walgreens Boots Alliance reported a sales growth of 8.6% to $35.4 billion in FY23 Q3 with an operating loss of $0.5 billion in the reported period.
On 27 Jun, Walgreens Boots Alliance released its FY23 Q3 results. The company reported sales of $35.4 billion with an increase of 8.6% and up 8.9% on a constant currency basis compared to the same period of last year.
During the third quarter, the operating loss of Walgreens Boots Alliance amounted to $0.5 billion, which is higher than the loss of $0.3 billion reported in the same quarter of the previous year. While the net earnings amounted to $118 million, a decrease from $289 million in the same quarter of the previous year, mainly due to lower operating income.
In the first nine months of fiscal 2023, sales for Walgreens Boots Alliance amounted to $103.7 billion, representing a 3.4% increase from the same period of the previous year. Adjusted for constant currency, the increase was 4.8%. However, the operating income for the first nine months of fiscal 2023 was a loss of $6.4 billion, which is a significant decrease from the operating income of $2.2 billion reported in the same period of the previous year.
In terms of the segment's performance, the U.S. Retail Pharmacy segment recorded sales of $27.9 billion in Q3, representing a 4.4 percent increase from the sales reported in the same quarter of the previous year.
The international segment reported sales of $5.6 billion, which is a 5% increase from the sales reported in the same quarter of the previous year. When adjusted for constant currency, the segment's sales increased by 6.9 percent, with Boots UK sales growing by 10.2% and the Germany wholesale business growing by 3.8%.
The U.S. Healthcare segment reported sales of $2.0 billion in the third quarter, which is a substantial increase of $1.4 billion compared to the sales reported in the same quarter of the previous year.
Walgreens Boots Alliance is a leading healthcare, pharmacy, and retail company based in Deerfield, Illinois. The company owns and operates the retail pharmacy chains Walgreens in the US and Boots in the UK, along with several pharmaceutical manufacturing and distribution companies.
Walgreens Boots Alliance has a workforce of over 325,000 employees and operates in nine countries through its portfolio of consumer brands, including Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico, and Ahumada in Chile. The company owns 13,000 locations across the U.S., Europe, and Latin America. Moreover, the company holds a range of healthcare-focused investments located in various countries, such as China and the United States.
Comments